Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - BARRIS PETER J
Last Updated 
4-Sep-15
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BARRIS PETER J: Declared Holdings
Company/RelationshipReportedShares  Ownership
ARCA biopharma, Inc.
Beneficial Owner (10% or more)
NasdaqCM:ABIO
(historical quotes, profile, other insiders)
16-Jun-1510,221,465  Indirect
Audience, Inc.
Beneficial Owner (10% or more)
NasdaqGS:ADNC
(historical quotes, other insiders)
5-Nov-131,441,344  Indirect
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
5-Jun-1510,293,211  Indirect
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
CHAMPIONS ONCOLOGY
Beneficial Owner (10% or more)
NasdaqCM:CSBR
(historical quotes, profile, other insiders)
11-Mar-1518,750,000  Indirect
Tableau Software, Inc. Class A
Beneficial Owner (10% or more)
NYSE:DATA
(historical quotes, profile, other insiders)
2-Dec-14140,821  Indirect
GlycoMimetics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:GLYC
(historical quotes, profile, other insiders)
15-Jan-148,575,135  Indirect
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
23-Dec-1435,298,087  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,789,420  Indirect
Roka Bioscience, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ROKA
(historical quotes, profile, other insiders)
22-Jul-143,216,810  Indirect
Sunesis Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqCM:SNSS
(historical quotes, profile, other insiders)
29-Aug-144,659,333  Indirect
Supernus Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:SUPN
(historical quotes, profile, other insiders)
17-Jun-157,716,055  Indirect
Vitae Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:VTAE
(historical quotes, profile, other insiders)
1-Jul-151,789,352  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Jul-15 *833,250VTAE Disposition (Non Open Market) at $0 per share.
1-Jul-15 *11,038VTAE Acquisition (Non Open Market) at $0 per share.
17-Jun-15 *111,881SUPN Sale at $16.02 - $16.67 per share.
(Proceeds of about $1,829,000)
16-Jun-15 *55,105SUPN Sale at $16.85 per share.
(Proceeds of $928,519)
16-Jun-15 *10,221,465ABIO Statement of Ownership
15-Jun-15 *1,162,791SUPN Acquisition (Non Open Market) at $0 per share.
15-Jun-15 *3,921,000SUPN Disposition (Non Open Market) at $0 per share.
5-Jun-15 *4,672,897ARDX Purchase at $10.70 per share.
(Cost of $49,999,997)
11-Mar-15 *18,750,000CSBR Statement of Ownership
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
22-Jan-15 *162,780BOX Statement of Ownership
26-Dec-14 *1,972ARDX Sale at $21.28 per share.
(Proceeds of $41,964)
23-Dec-14 *2,552ARDX Acquisition (Non Open Market) at $0 per share.
23-Dec-14 *10,000ARDX Disposition (Non Open Market) at $0 per share.
23-Dec-14 *19,868,965ILIU Purchase at $0.10 per share.
(Cost of $1,986,896)
2-Dec-14 *1,633,750DATA Disposition (Non Open Market) at $0 per share.
2-Dec-14 *1,734,494DATA Acquisition (Non Open Market) at $0 per share.
29-Aug-14 *11,600SNSS Sale at $7.51 per share.
(Proceeds of $87,116)
28-Aug-14 *146,800SNSS Sale at $7.87 per share.
(Proceeds of $1,155,316)
27-Aug-14 *108,300SNSS Sale at $8.17 per share.
(Proceeds of $884,811)
25-Aug-14 *7,099DATA Sale at $60.40 per share.
(Proceeds of $428,779)
22-Aug-14 *52,312DATA Sale at $60.46 - $61.02 per share.
(Proceeds of about $3,177,000)
21-Aug-14 *30,000DATA Sale at $59.19 - $59.79 per share.
(Proceeds of about $1,785,000)
20-Aug-14 *2,100,474DATA Disposition (Non Open Market) at $0 per share.
20-Aug-14 *2,229,962DATA Acquisition (Non Open Market) at $0 per share.
12-Aug-14 *35,540SNSS Sale at $6.76 per share.
(Proceeds of $240,250)
8-Aug-14 *675,000SNSS Sale at $6.62 per share.
(Proceeds of $4,468,500)
6-Aug-14 *230,769LOXO Purchase at $13 per share.
(Cost of $2,999,997)
6-Aug-14 *1,558,651LOXO Acquisition (Non Open Market)
22-Jul-14 *383,333ROKA Purchase at $12 per share.
(Cost of $4,599,996)
22-Jul-14 *2,828,743ROKA Acquisition (Non Open Market)
16-Jul-14 *4,734ROKA Statement of Ownership
7-Mar-14 *143,851DATA Sale at $90.62 - $93.07 per share.
(Proceeds of about $13,212,000)
6-Mar-14 *50,000DATA Sale at $94.32 - $96.13 per share.
(Proceeds of about $4,761,000)
5-Mar-14 *35,000DATA Sale at $94.28 - $95.34 per share.
(Proceeds of about $3,318,000)
4-Mar-14 *2,229,979DATA Acquisition (Non Open Market) at $0 per share.
4-Mar-14 *2,100,474DATA Disposition (Non Open Market) at $0 per share.
4-Mar-14 *10,804DATA Sale at $97.31 per share.
(Proceeds of $1,051,337)
3-Mar-14 *30,000DATA Sale at $95.14 - $96 per share.
(Proceeds of about $2,867,000)
27-Feb-14 *118,756DATA Sale at $94.47 - $97.11 per share.
(Proceeds of about $11,376,000)
26-Feb-14 *4,200,949DATA Disposition (Non Open Market) at $0 per share.
26-Feb-14 *4,459,855DATA Acquisition (Non Open Market) at $0 per share.
15-Jan-14 *1,000,000GLYC Purchase at $8 per share.
(Cost of $8,000,000)
15-Jan-14 *6,988,160GLYC Acquisition (Non Open Market)
9-Jan-14 *586,975GLYC Statement of Ownership
5-Nov-13 *2,573ADNC Sale at $9.83 per share.
(Proceeds of $25,292)
4-Nov-13 *1,453,393ADNC Disposition (Non Open Market) at $0 per share.
4-Nov-13 *18,131ADNC Acquisition (Non Open Market) at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?